BDBM50110057 3-Fluoro-4-hydroxy-benzoic acid [1-[4-(4-isopropyl-benzyloxy)-3,5-dimethoxy-phenyl]-meth-(E)-ylidene]-hydrazide::CHEMBL159071
SMILES: COc1cc(\C=N\NC(=O)c2ccc(O)c(F)c2)cc(OC)c1OCc1ccc(cc1)C(C)C
InChI Key: InChIKey=CEMWFAKZKSWOAF-CCVNUDIWSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon receptor (Homo sapiens (Human)) | BDBM50110057 (3-Fluoro-4-hydroxy-benzoic acid [1-[4-(4-isopropyl...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description In vitro inhibitory activity against human glucagon receptor using [127I]-labeled glucagon | Bioorg Med Chem Lett 12: 663-6 (2002) BindingDB Entry DOI: 10.7270/Q2J67G77 | |||||||||||
More data for this Ligand-Target Pair |